drugset / Trial / NCT03375671
Rapid Agitation Control With Ketamine in the Emergency Department
Phase 2
Completed
81 enrolled
David Barbic
Centre for Health Evaluation and Outcome Sciences (CHÉOS) · collabSt Paul's Emergency Department Research Fund · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Compare intramuscular (IM) ketamine to a combination of IM midazolam and haloperidol with regards to the time required for adequate behavioral control, in minutes, in patients presenting to the emergency department with psychomotor agitation and violent behavior.
Timeline
- Start
- 2018-05-29
- Primary completion
- 2020-03-12
- Completion
- 2020-03-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Haloperidol | Other / unclassified | 5 mg | Intramuscular |
| Subject | Ketamine | Small molecule | 5 mg/kg | Intramuscular |
| Comparator | Midazolam | Small molecule | 5 mg | Intramuscular |
Indications
No indication recorded.